جست‌وجوی استاد و پژوهشگر

• Applied Nuclear Physics
• Medical Physics
• Radiation Oncology
• +۵ مورد دیگر

Assoc Prof Jeremy Brown is an Associate Professor at Swinburne University of Technology's School of Science, Computing and Emerging Technologies, leading a research program in Applied Nuclear Physics since 2023. He holds a PhD from Monash University and has held postdoctoral positions at Queen's University Belfast (2015-2016) and Delft University of Technology (2017-2021), where he secured an NWO Veni Fellowship. His research focuses on imaging physics, Monte Carlo radiation transport, nuclear safety, radiotherapy, and space radiation effects. Education: PhD in Imaging Physics (Monash University, Australia). Postdoctoral research includes radiobiology (Queen's Belfast) and medical imaging at Delft University (Veni Fellowship recipient). Prior roles include Research Scientist at ARPANSA (2007-2009) and ANSTO (2021-2022). Research interests span medical physics applications of Geant4 simulations, radiation dosimetry, proton therapy optimization, space radiation exposure modeling, and collaborative projects with Philips Healthcare, ESA, and CNRS. His work emphasizes bridging computational physics with clinical and industrial applications. Key grants include an NWO Veni Fellowship (2017-2021) and recent projects like 'A portable dosimetry system for space radiation qualification' (2025) and 'Setting a national standard for radiotherapy treatment' (2025-2028). He collaborates with leading institutions like HollandPTC, ANSTO, and European agencies. Publications focus on Geant4 validation, radiation detector modeling, and radiobiological studies, with over 50 peer-reviewed articles. Notable contributions include the G4-Med benchmarking system and advancements in DNA damage simulation.

Valery Vishnevskiyمشاهده پروفایل

مدرس

• Biomedical Imaging
• Magnetic Resonance Imaging (MRI)
• Ultrasound Imaging
• +۳ مورد دیگر

Dr. Valery Vishnevskiy is a Lecturer at the Department of Information Technology and Electrical Engineering at ETH Zürich , affiliated with the Biomedical Imaging Group . His research focuses on advanced medical imaging techniques, particularly in cardiac MRI , ultrasound , and machine learning applications . He contributes to projects involving 4D flow MRI reconstruction , speed-of-sound imaging , and motion-corrected diffusion tensor analysis . Primary Affiliation : ETH Zürich, Department of Information Technology and Electrical Engineering Research Interests : Biomedical Imaging, MRI Reconstruction, Ultrasound Physics, Cardiac Imaging, Deep Learning His recent work emphasizes self-supervised learning for medical imaging, including the development of FlowMRI-Net for accelerated 4D flow MRI and Speed-of-Sound Imaging using diverging waves. Publications span hyperpolarized 13C metabolic imaging , viscoelasticity reconstruction , and probabilistic sampling optimization . Dr. Vishnevskiy's contributions to deformable image registration include methods for handling sliding interfaces in abdominal and cardiac imaging, with applications in respiratory motion compensation and tissue ablation monitoring . He also explores mathematical models for enzyme activity analysis and behavioral pattern detection.

Anatoly Rozenfeldمشاهده پروفایل

استاد

• Medical Physics
• Radiation Therapy
• Nuclear and Plasma Physics
• +۳ مورد دیگر

Anatoly Rozenfeld is a Distinguished Professor and Director of the Centre for Medical Radiation Physics (CMRP) at the University of Wollongong (UOW), School of Physics. He leads research in semiconductor radiation detectors, micro-dosimetry, and advanced radiation therapies. His work spans applications in cancer treatment, space medicine, and radiation protection. He holds editorial roles in journals like Medical Physics and chairs international conferences such as SSD 16 and IEEE NSS/MIC. Education: PhD in Physics, Kiev Institute for Nuclear Research (1991) MSc (Distinction) in Semiconductor Physics, Leningrad Polytechnic Institute (1974) Research Interests: Focuses on medical radiation physics innovations, including proton therapy, heavy-ion therapy, and space radiation monitoring. His lab develops novel detectors like 'MagicPlates' for high-resolution dosimetry and explores 3D bioprinting for tumor models in radiation studies. He also investigates shielding strategies for deep-space missions. Grants & Awards: $17M+ in competitive grants, including NHMRC and ARC funding 2022 NSW Premier’s Outstanding Cancer Researcher Award IEEE NPSS Glenn F. Knoll Award for Radiation Instrumentation (2023) Advisory Roles: Member of ICRU Micro-dosimetry Committee, Australian Space Agency’s Space Medicine Committee, and the Australian National Hadron Therapy Steering Committee. Lab/Teams: Leads CMRP, a globally recognized center with CAMPEP accreditation and ERA ‘above world standard’ ratings (2015, 2018).

Rozemarijn Vliegenthartمشاهده پروفایل

استاد

• Cardiothoracic Radiology
• Epidemiology
• Large-scale Imaging Studies
• +۳ مورد دیگر

Prof. Rozemarijn Vliegenthart is a Professor and Radiologist at the University of Groningen's Faculty of Medical Sciences, Department of Radiology. She holds leadership roles including President of the European Society of Cardiovascular Radiology and Fellowships with the International Cancer Imaging Society and North American Society for Cardiovascular Imaging. Her research focuses on cardiothoracic radiology, epidemiology, and large-scale imaging studies, with a particular emphasis on AI integration in radiology and cardiovascular imaging outcomes. She has contributed to over 390 publications and is actively involved in editorial roles for journals like Radiology and European Journal of Radiology . Key research areas: Pulmonary nodules, cardiovascular MRI/CT, AI-driven diagnostics, and imaging biomarkers. Leadership: Editor roles, society presidencies, and global guideline development. Her work bridges clinical practice and innovation, addressing topics like lung cancer screening, coronary artery disease imaging, and the ethical use of AI in healthcare. Awards & Affiliations Fellowships: International Cancer Imaging Society, North American Society for Cardiovascular Imaging. Editorial Boards: Radiology (Consultant to the Editor), Journal of Thoracic Imaging (Consulting Editor for Statistics). Grants & Collaborations Involved in major initiatives like the MEDIRAD study on radiation effects and the ImaLife cohort for imaging biomarkers. Collaborates internationally on CT/MRI protocols, AI frameworks, and population health studies. Labs & Teams Part of the Medical Imaging Center and interdisciplinary teams at the Cardiovascular Centre (CVC) and BRIDGE research group, focusing on translational imaging and digital health advancements.

• Diabetes in Pregnancy
• Women's Health
• Endocrinology
• +۳ مورد دیگر

Dr. Suja Padmanabhan is a Clinical Lecturer at the University of Sydney's Westmead Clinical School and Staff Specialist in Diabetes and Endocrinology at Westmead Hospital. She holds a PhD (2017) from the University of Sydney, focusing on insulin requirements and placental dysfunction in pre-existing diabetes during pregnancy. Her research emphasizes diabetes in pregnancy, particularly maternal-fetal outcomes in women with type 1 and type 2 diabetes, and pre-conception health optimization. Education MBBS (hons) BSc(Med) MPHTM FRACP PhD (University of Sydney) Research Themes Obesity, Diabetes and Cardiovascular Disease Reproductive, Maternal and Child Health Her work addresses gestational diabetes management, breastfeeding's metabolic impacts, and preeclampsia prediction using biomarkers like microalbuminuria and urinary angiogenic markers. Key Contributions include the BLIiNG study on breastfeeding and postpartum glucose tolerance, and the ADIPS national benchmarking program for diabetes in pregnancy care. She has also explored aspirin's role in preeclampsia prevention and insulin dynamics in diabetic pregnancies.

• Genetic Toxicology
• Human Health Risk Assessment
• Dose Response Modelling
• +۳ مورد دیگر

George Johnson is an Associate Professor in Biomedical Sciences at Swansea University's Faculty of Medicine, Health and Life Science. He serves as Director of Employability and Entrepreneurship for the Medical School and teaches on the Genetics Degree programme. His research is conducted within the DNA damage group (in vitro Toxicology group) at the Institute of Life Science. Johnson's research focuses on genetic toxicology, human health risk assessment, dose response modeling, and imaging flow cytometry. His work bridges fundamental research in DNA damage mechanisms with practical applications in pharmaceutical risk assessment, particularly regarding N-nitrosamine impurities. He has developed advanced methodologies for benchmark dose analysis and quantitative risk assessment that have been adopted by regulatory agencies worldwide. His publication record shows a strong trend toward increasingly sophisticated quantitative approaches to genetic toxicology, with recent work focusing on N-nitrosamine risk assessment, imaging flow cytometry applications, and development of frameworks for translating in vitro genotoxicity data to in vivo risk predictions. The 2023-2025 publications demonstrate growing emphasis on computational modeling and quantitative risk assessment methodologies. UKEMS Young Scientist Award (2012) Fellow of the Higher Education Academy (2013) British & European Registered Toxicologist (2014) EEM(G)S Young Scientist Award (2014) Elected President of EEMGS society (2019) Johnson actively supervises postgraduate research, with current projects focusing on deep learning applications for genotoxicity assessment, mutagenicity of compounds using benchmark dose analysis, and validation of mutagenicity assays for nitrosamine assessment. He has led numerous international collaborations with organizations including US-FDA-NCTR, Health Canada, RIVM-Netherlands, and major pharmaceutical companies. As a consultant through Swansea Innovations, he works with pharmaceutical, food additive, and chemical industries on deriving point of departure metrics for human health risk assessments. He is a steering member and co-chair of subgroups for the Health and Environmental Sciences Institute (HESI) Genetic Toxicology Technical Committee, providing an international forum for advancing understanding of scientific issues related to human health, toxicology, and risk assessment.

• Medical Imaging
• Radiation Therapy
• Machine Learning
• +۳ مورد دیگر

Jie Wei is a Professor of Computer Science at the City College of New York (CCNY), with an affiliation to the Computer Engineering department. His work bridges computer vision, medical imaging, and machine learning with applications in radiation therapy, infrastructure monitoring, and disaster mitigation. Dr. Wei's research focuses on developing intelligent systems for medical diagnostics, autonomous object detection, and environmental safety assessment. His team pioneers techniques like SAM-based auto-segmentation for clinical applications and uses transfer learning for non-invasive motion tracking in oncology. Education details are listed on CCNY's site but not explicitly provided here. His research spans over 15 years, with notable contributions to 4D medical imaging analysis, lung tumor tracking, and lidar-based infrastructure monitoring. Recent work emphasizes AI-driven solutions for radiation therapy complications, autonomous vehicle classification, and efficient damage assessment systems. Publications reflect a strong trend towards interdisciplinary applications of machine learning, particularly in healthcare and civil engineering. His work often integrates deep learning models with domain-specific challenges, such as real-time CCTV threat detection and volumetric respiratory motion simulation. Collaborations likely span biomedical engineering, computer science, and civil infrastructure sectors.

Andrea Espejo Freireمشاهده پروفایل

استادیار

• Oncology
• Sarcoma Research
• Translational Medicine
• +۵ مورد دیگر

Andrea Espejo Freire, MD serves as Assistant Professor of Medicine in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota Medical School. Her clinical expertise focuses on sarcomas and rare tumors, with active research in translational oncology and clinical trials for desmoid tumors, gastrointestinal stromal tumors (GIST), and leiomyosarcoma. Dr. Espejo Freire's research centers on multiomic characterization of sarcoma biology, particularly DNA damage response pathways, tumor immunology, and mechanisms of therapy resistance. Her work integrates genomic, transcriptomic, and clinical data to identify biomarkers for treatment selection and develop novel therapeutic strategies for rare malignancies. Key methodologies include national database analyses, circulating tumor DNA monitoring, and comparative effectiveness studies of systemic therapies. Analysis of her 2021-2025 publications reveals three dominant research trajectories: (1) molecular subtyping of sarcomas by age group and anatomical origin, (2) optimization of targeted therapies (particularly sorafenib) for desmoid tumors, and (3) exploration of immunotherapy resistance mechanisms in leiomyosarcoma. Her work consistently bridges laboratory findings with clinical applications through retrospective cohort studies and single-institution case series.

• Vaccinology
• Infectious Diseases
• Immunology
• +۳ مورد دیگر

Sir Andrew J Pollard serves as the Ashall Professor of Infection & Immunity at the University of Oxford and Director of the Oxford Vaccine Group. He concurrently holds positions as Consultant in Paediatric Infectious Disease at Oxford Children's Hospital, Fellow of St Cross College, and Chair of the UK Health Department's Joint Committee on Vaccination and Immunisation (JCVI). His work operates within the Department of Paediatrics at the University of Oxford, driving global vaccine research initiatives. Pollard's research program centers on vaccinology and infectious disease immunology, with pioneering contributions to childhood immunisation and outbreak response. His team has led clinical development of vaccines for meningococcal disease, Ebola, influenza, typhoid, and SARS-CoV-2 through rigorous phase I-III trials. Notable achievements include establishing human challenge models for typhoid and demonstrating real-world vaccine impact in low-income settings, directly influencing WHO policy recommendations. Current work focuses on optimising immunisation schedules in resource-limited regions and developing next-generation vaccine platforms. His 2025 publications reveal three critical research trajectories: evaluation of novel vaccine delivery technologies through public attitude metrics; cost-effectiveness modeling for respiratory virus vaccines in aging populations; and mechanistic studies of immune responses to pathogens like measles and typhoid. These works demonstrate his dual focus on immediate pandemic response and long-term vaccine infrastructure development across diverse global contexts. Pollard's scientific recognition includes: Knighthood for exceptional contributions to vaccinology University of Oxford's Vice Chancellor's award for innovation (2020) for typhoid vaccine implementation As Director of the Oxford Vaccine Group, Pollard commands substantial research funding from global health agencies and governments, enabling large-scale international trials across 50+ sites. His leadership in the Oxford-AstraZeneca COVID-19 vaccine program—which delivered 3 billion doses worldwide—exemplifies his capacity to rapidly mobilise multinational collaborations. While specific student mentorship isn't detailed, his group trains numerous clinical researchers through hands-on trial management in both UK and endemic settings. The Oxford Vaccine Group maintains a 30-year research infrastructure spanning laboratory science, clinical trial units, and field sites in Nepal, Bangladesh, and Uganda. Current flagship projects include the TyVAC consortium evaluating typhoid conjugate vaccines in Africa and Asia, and the PneuCarriage study tracking pneumococcal transmission dynamics. Pollard's Kathmandu-based partnership with Patan Hospital serves as a model for sustainable research capacity building in low-resource environments.

Vincent Lamirandمشاهده پروفایل

مدرس

• Radiation Detection
• Instrumentation
• Reactor Physics
• +۷ مورد دیگر

Vincent Lamirand is a Lecturer and Tenured Scientist at École polytechnique fédérale de Lausanne (EPFL), working within the School of Basic Sciences, Institute of Physics, and Laboratory for Reactor Physics and Systems Behaviour (LRS). He serves as Program Manager of Experimental Research and Deputy Head of LRS Nuclear Facilities, overseeing experimental activities at the CROCUS experimental reactor and LOTUS cavity. Additionally, he is one of four Scientific Staff Members at the School Assembly, Basic Sciences Faculty Council, and Institute of Physics Council. Dr. Lamirand's educational background includes: PhD in Nuclear Physics from UJF Grenoble 1 (France), 2011 Master Degree in Physics, specializing in Subatomic Physics from UCB Lyon 1 (France), 2008 Bachelor Degree in Physics from UCB Lyon 1 (France), 2006 Dr. Lamirand's research focuses on experimental reactor physics, with emphasis on radiation detection, instrumentation, and measurement techniques for nuclear systems. His work spans neutron and gamma noise analysis, reactor kinetics parameter determination, and high-resolution flux mapping in zero-power reactors. He has pioneered the development of miniature neutron detectors and 3D core-mapping systems like SAFFRON, enabling unprecedented spatial resolution in reactor measurements. His research addresses fundamental questions in reactor physics while providing validation data for advanced simulation codes. His recent publication trend shows a strong focus on neutron and gamma noise analysis in zero-power reactors, particularly through the CORTEX project. He has developed novel methodologies for transfer function determination, uncertainty quantification, and prompt decay constant measurements. His work bridges experimental reactor physics with computational methods, providing valuable validation data for high-fidelity transport codes. The PETALE and BLOOM experimental programs demonstrate his commitment to nuclear data validation, particularly for stainless steel reflectors. Dr. Lamirand actively mentors students at all levels, supervising PhD candidates, Master's theses, semester projects, and internships. His advising spans experimental design, data analysis, and computational methods in reactor physics. While specific grant information isn't detailed in the provided text, his extensive publication record and leadership in major experimental programs like CORTEX, PETALE, and BLOOM suggest significant research funding support. He leads experimental work at the CROCUS zero-power research reactor, operating the LOTUS cavity and developing advanced instrumentation like the SAFFRON 3D core-mapping system with 160 miniature detectors. His laboratory focuses on high-precision measurements for reactor physics validation, nuclear data improvement, and innovative monitoring techniques for nuclear facilities.

Abigail Aikenمشاهده پروفایل

دانشیار

• Reproductive Health Policy
• Abortion Research
• Global Health
• +۳ مورد دیگر

Abigail Aiken serves as Associate Professor of Public Affairs and Fellow of the Richter Chair in Global Health Policy at The University of Texas at Austin's College of Liberal Arts. She teaches undergraduate courses including Sex/Society: Soc, Bio, Pol across multiple semesters (2021-2025). Education: MD, Cambridge University MPH, Harvard University PhD, The University of Texas at Austin Research Focus: Dr. Aiken's work centers on reproductive health policy with emphasis on abortion access , self-managed medication abortion , and telemedicine implementation in restrictive legal environments. Her research examines patient experiences, policy impacts (particularly post-Dobbs), and healthcare system adaptations through mixed-methods approaches combining epidemiological analysis with qualitative patient narratives. Publication Trends: Recent scholarship demonstrates escalating focus on self-managed abortion safety (2022-2024), telemedicine adaptation to shield laws (2024-2025), and quantitative analysis of policy impacts following Roe's overturning. Her work consistently bridges clinical outcomes with policy analysis across 40+ publications since 2022. Scientific Recognition: Richter Chair in Global Health Policy Fellowship David N. Kershaw Award for policy-relevant reproductive health research Professional Context: Dr. Aiken operates at the critical intersection of clinical practice, policy advocacy, and academic research. Her work directly informs legislative debates through rigorous evidence generation while maintaining active clinical engagement via telemedicine platforms. Current efforts focus on developing sustainable care models for the post-Roe landscape with particular attention to vulnerable populations.

• Chemical Safety Assessment
• Safe and Sustainable by Design (SSbD)
• Toxicogenomics
• +۱۲ مورد دیگر

Dr. Angela Serra is a University Lecturer in the Department of Biomedicine at the Faculty of Medicine and Health Technology, Tampere University, Finland. Her research bridges computer science and biomedicine, focusing on data integration, toxicogenomics, and Safe and Sustainable by Design (SSbD) frameworks for chemical and nanomaterial safety assessment. Her primary research interests include chemical safety assessment , knowledge graphs in drug discovery , toxicogenomics , network toxicology , and computational modeling of adverse outcome pathways . She applies advanced data science and systems biology methods to develop innovative, non-animal approaches for evaluating chemical and nanomaterial risks. The recent publications highlight a strong trend toward integrated data frameworks , digital innovation in sustainability , and mechanistic modeling for regulatory science. Her work emphasizes the use of omics data, knowledge graphs, and AI-driven tools to support Safe and Sustainable by Design (SSbD) principles in chemical and material innovation. Dr. Serra is actively involved in EU-funded research, currently serving as a Work Package Leader in the INSIGHT project under Horizon Europe. She contributes to major collaborative efforts such as the PINK and CompSafeNano projects, advancing digital and data-driven approaches in toxicology and sustainability. She has developed several software tools including Nextcast , BMDx , and MaNGA , supporting toxicogenomics analysis, benchmark dose modeling, and QSAR modeling. These tools are publicly available and contribute to open science in computational toxicology.

Rob Mestromمشاهده پروفایل

استادیار

• Electromagnetics
• Medical Applications
• Neurostimulation
• +۵ مورد دیگر

Dr. Rob Mestrom is an Assistant Professor at the Electromagnetics Research Group, Department of Electrical Engineering, Eindhoven University of Technology (TU/e). With over 15 years of experience in multiphysics modeling and electromagnetic applications, he focuses on medical neuromodulation using transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) , alongside deep hyperthermia optimization for oncology treatments. 2005 MSc in Mechanical Engineering (cum laude), TU/e 2009 PhD in Dynamics & Control, TU/e His research combines electromagnetic field modeling with thermal and acoustic properties to develop personalized medical treatments , particularly for neurological disorders. Key projects include: Polynomial Chaos Expansion methodologies for uncertainty quantification in LIFUS applications Development of quantitative multinuclear MRI techniques for dielectric tissue characterization Investigations into peripheral nerve contributions in tDCS mechanisms He contributes to public-private partnerships through Health Holland collaborations and serves on the Dutch Health Council's Electromagnetic Fields Committee since 2017.

• Statistics
• Applied Statistics
• Precision Agriculture
• +۳ مورد دیگر

Signe Marie Jensen is an Associate Professor in the Department of Plant and Environmental Sciences at the University of Copenhagen's Faculty of Science. Her research bridges statistical methodology with agricultural applications, focusing on precision agriculture and plant phenotyping. She leads innovative work applying computer vision and machine learning to solve critical agricultural challenges. Education: MSc in Mathematical Economics, University of Copenhagen (2007) PhD in Applied Statistics, University of Copenhagen (2015) Dr. Jensen's research interests center on statistical methods for simultaneous inference and analysis of phenotyping data. Her work has increasingly focused on applying advanced machine learning techniques, particularly YOLO algorithms, to agricultural challenges including pest detection, weed management, and plant phenotyping. She develops statistical frameworks that enable more accurate and efficient analysis of complex agricultural data. Her recent publications reveal a strong trend toward interdisciplinary research combining statistics, computer vision, and plant science. The majority of her 2024-2025 publications focus on applying YOLO-based object detection systems to agricultural problems, particularly in precision farming applications. These works demonstrate her ability to translate statistical theory into practical agricultural technologies that address food security and sustainable farming challenges. Dr. Jensen's research output shows strong international collaboration, with co-authors from multiple countries working on agricultural technology development. Her work on the PhenoLab platform represents a significant contribution to high-throughput plant phenotyping infrastructure. She maintains active research in both theoretical statistics (simultaneous inference methods) and applied agricultural technology development, demonstrating remarkable versatility across these domains. Her current work on deep learning applications for crop monitoring represents the cutting edge of precision agriculture research.

John Kenneth Colbourneمشاهده پروفایل

استاد

• Environmental Genomics
• Evolutionary Ecology
• Toxicology
• +۵ مورد دیگر

John Kenneth Colbourne serves as Professor and inaugural Chair of Environmental Genomics at the University of Birmingham's School of Biosciences, where he also directs the Centre for Environmental Research and Justice (CERJ). He holds adjunct professorship at the Mount Desert Island Biological Laboratory and maintains leadership roles in multiple international genomics consortia. His research program integrates evolutionary ecology, high-throughput biology, and environmental genomics to investigate gene-environment interactions using Daphnia as a model organism. Key research areas include molecular mechanisms of developmental plasticity, genomic signatures for environmental health protection, forecasting ecological threats through Daphnia egg bank genomics, and biostatistical methods for high-dimensional data analysis. Analysis of his 15 most recent publications (2024-2025) reveals a strong focus on environmental toxicology, with particular emphasis on chemical mixture effects, neurotoxicity mechanisms, and the development of New Approach Methodologies (NAMs) for chemical safety assessment. His work demonstrates consistent application of Daphnia and zebrafish models alongside multi-omics approaches. Royal Society Wolfson Research Merit Award Co-chair of 2012-13 Gordon Research Conference on Ecological and Evolutionary Genomics Professor Colbourne actively collaborates with industry and advises government agencies on transforming environmental monitoring practices through molecular biology methods. He serves as Section-Editor for BMC Genomics, Founding Editor of Ecological and Environmental Genomics, and coordinates multiple BioMed Central publication series focused on Daphnia genomics. His leadership extends to founding roles in the Daphnia Genomics Consortium, Shanghai Consortium for Environmental Genomics and Toxicology, and several other international genome initiatives.